chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After receiving the second dose of the Moderna vaccine, I began exhibiting chills and had some fatigue that afternoon. At 2am, I woke up with a 102.5 degree fever. I took Tylenol at 3:30am. When I woke up for the day, I had a fever between 101-103 degrees all day and felt fatigued. As of today, Sunday, 2/21/22, I still have an elevated temp around 100 degrees a headache, and fatigue.
Rib pain; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL CHEST PAIN (Rib pain) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis and Parkinson's disease.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL CHEST PAIN (Rib pain). At the time of the report, MUSCULOSKELETAL CHEST PAIN (Rib pain) had resolved.            No treatment medication were provided. No concomitant medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.
A very slow onset of symptoms post injection,the injection site itself remained tender for months (the needle hole is still visible today) but the left shoulder pain  only started to become noticeable after two week, at first it was minor pain but with each succeding month it got sharper and started to impede daily activities.After the 4th month with worsening mobility and often very severe pain, I made an appointment with my doctor who referred me to the hospital for physiotherapy. Their initial diagnosis is a form of frozen shoulder,the physiotherapist recommended that I contact VAERS to fill out an adverse reaction report to the J&J vaccine.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2012, the patient was inoculated at a pharmacy with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. During 2015, the patient was treated at physician office for persistent and severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Approximately 27 hours after Td, pt developed muscle aches, muscle cramps and fever ranging from 103-105 orally; took 800 mg Motrin at 4:30pm, 7:30pm, 12AM, sxs gone by 12AM
pt recv vax & devel a diffuse maculopapular rash 1wk p/vax;sx currently resolved;
Allergic dermatitis (L23.9). Broke out in hives 01/23/2021 (not due to anything by mouth).
This spontaneous report as received from a pharmacist refers to a 63 year old female patient with no drug reactions/allergies. On 10-MAR-2014 the patient was vaccinated with a dose of ZOSTAVAX 19400PFU (lot # J001697, expiration date 08-MAY-2014, dose not reported) subcutaneous for preventing shingles. Concomitant therapies included Lisinopril (manufacturer unknown), Latanoprost and Hydrochlorothiazide, Dyazide. On an unknown date in March 2014 the patient experienced a large, red, warm and swollen arm red area down the back of her arm where ZOSTAVAX was administered subcutaneously. No lab diagnostics studies performed. The patient sought medical attention via contacting pharmacist. The outcome of the events was reported as not recovered. Additional information has been requested.
Chest pain on left side under ribs; Fatigued; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 20Apr2021 at 13:30 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient reported allergies as not applicable. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in left arm on 27Mar2021 at 14:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 17:00, 27 hours after second dose of vaccination, the patient experienced chest pain on left side under ribs and was also fatigued. Chest pain lasted 3 or so hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chest pain on left side under ribs and fatigued was recovered on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
This case was reported by a healthcare professional (nurse) and described the occurrence of nausea in a subject of unspecified age and gender who was vaccinated with FLULAVAL (GlaxoSmithKline). In 2013 the subject received a dose of FLULAVAL (unknown details). In 2013, within months of vaccination with FLULAVAL, the subject experienced nausea, syncope and flushing. At the time of reporting the outcome of the events were unspecified. The healthcare professional reported another case with FLULAVAL. See case A1043170A for details on the other case.
a 5 year old male patient was inadvertently administered expired dose of Daptacel/ no ae; Initial information received on 23-May-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case involves a five years old male patient who was inadvertently administered expired a 0.5ml once dose of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] lot C5190AA, Expiration Date: 24-APR-2019 via intramuscular route in the left deltoid on 22-May-2019.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to expired vaccine used. A 5 year old male patient was inadvertently administered expired dose of Daptacel.  None adverse event symptoms reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
Patient stated first dose of Novavax vaccine. After vaccine administration, nurse noticed that the moderna primary series + 1 moderna booster had already been administered to the patient. Since Novavax is only licensed as a primary series dose, nurse chose to report the incident.
Expired dose of IPOL vaccine was administered with no reported adverse event; Initial information received on 15-Oct-2021 regarding an unsolicited valid non-serious case from an other health professional via Media information (under the reference 00814960).  This case involved a 5-year- old female patient who received an expired dose of POLIOMYELITIS VACCINE (INACTIVATED)[IPOL] (expired product used).  Concomitant medication was included MEASLES VACCINE, MUMPS VACCINE, RUBELLA VACCINE, and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID [DTAP]   Medical history, medical treatment, vaccination and family history were not provided.  On 14-Oct-2021, the patient received a 0.5 mL dose of suspect IPV (VERO) [lot R1F801M, expiry date: 28-Sep-2021] via intramuscular route at a right deltoid for prophylactic vaccination.  It was an actual medication error due to expired vaccine used (same day).  It was reported " Caller states that a patient received an IPOL vaccine in her clinic on 14-Oct-2021 that had expired on 28-Sep-2021. Caller states that the multidose vial (MDV) was unopened prior to this administration and that only 1 patient received the expired IPOL. Caller states that this was an open clinic for patients without doctors and did not provide a doctor's name."  At the time of reporting, the patient experienced no adverse event.  This suspected adverse reaction report was submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error was in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party had contributed to or is to be held liable for the occurrence of this medication error.
I started having ringing in my ears around the 19th of March. I still have it. Within a day or two of the ringing of the ears, my feet and legs swelled up, I still have swelling at least 3x a week.
When I caught COVID it started as a persistent cough. Then I got a runny nose and started sneezing. A few days into it I had shortness of breath. Then I went to get tested for COVID. I was positive. I had a low grade fever, body aches, fatigue, a stuffy nose, and congestion. I was taking Mucinex and Tylenol in rotation to relieve my symptoms. The symptoms lasted up until April 1, 2022.
Pt received her first dose of the COVID19 vaccine and within minutes she began to feel light headed. Pt had a near syncopal episode where she reported brief hearing loss. Pt reports this happens to her with injections often. EMS called and  came to evaluate pt.  BP 90/60 HR 66 O2 Sat 98% Repeat BP 153/90 HR 69 98%  Sitting up BP 140/78 HR 70 97%   Pt reported feeling better and signed refusal for transport to the hospital EMS. Pt was advised to contact her PCP and given the information for the high risk clinic for her 2nd dose.
Fatigue; Leg pain mostly right leg, upper thigh area; Lower back pain; Calf pain; First night after vaccine sharp abdominal pain. Didn't last long.; This is a spontaneous report from a contactable healthcare professional, the patient. A 66-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10Apr2021 (at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included insomnia. Concomitant medications were not reported. The patient previously took morphine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced sharp abdominal pain, didn't last long. On 11Apr2021, the patient experienced fatigue, then leg and lower back pain which was persistent, leg pain mostly right leg, upper thigh area at times, calf pain. The patient reported that it was really hard to say when it actually started but it appeared to have started after having vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event sharp abdominal pain recovered on an unspecified date in Apr2021. While that of leg and lower back pain, leg pain mostly right leg, upper thigh area at times, calf pain was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a physician via call center representative and described the occurrence of suspected vaccination failure in a adult female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX. On an unknown date, several weeks after receiving SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved. It was unknown if the reporter considered the vaccination failure and shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported, but it could 71 years or 72 years. The healthcare professional reported that the patient received experienced shingles few weeks later of vaccination. Shingles did resolve within 3 to 4 weeks. The healthcare professional stated that the patient did not get vaccine at their facility so had no information on administration of product. This case was considered to be a suspected vaccination failure case, as the details regarding completion of vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown.
Reported onset of frontal headache before leaving vaccination observation area on 5 April; headache later resolved after taking Naproxen and has not returned. Patient also experienced feeling sweaty and clammy evening of vaccine receipt; did not measure temperature; no chills; symptoms did not interfere with sleep and were resolved upon awakening on 6 Apr.. On evening of 5 Apr and on 6 Apr, patient reported generalized achiness diminished after taking Naproxen; aching did not change much between 5 and 6 Apr (no worsening); no joint swelling, warmth, or redness. Also noted "rash" within 2-3 hours of vaccine receipt - not pruritic and only located in antecubital area of left (vaccinated) arm (review of photo showed round/oval, erythematous patch about 3x3, possibly Herald patch); no significant local vaccination site reaction of left upper extremity or axillary tenderness and swelling.    Denied symptoms c/w immediate allergic reaction [any hypersensitivity-related signs or symptoms consistent with urticaria, angioedema, respiratory distress (e.g., wheezing, stridor), or anaphylaxis that occur within four hours following administration  On 8 Apr, patient reports all symptoms gone except red area on left antecubital, which seems to be getting better
Leaving messages for patient about the second shot and finally reached patient today.  Patient was weak and shaking for 5 days after the first shot and did not want to take the second dose.
patient Had his flu shot, but it still got to him; Initial information received from on 21-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer.  This case involves Adult and unknown gender patient who reported that he/she had a flu shot, but it still got to him after receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect Influenza vaccine produced by unknown manufacturer (with unknown formulation, strength, route, lot number, Expiry date and at unknown administration site) for flu(influenza) .  On an unknown date, the patient was diagnosed with flu (influenza) (unknown latency) following the administration of Influenza vaccine.  No lab data were reported.  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
I experienced some flu-like symptoms like body aches, chills, muscle pain at the injection site feeling having mild fever (I didn't measure though), feeling tired.
My throat / tongue swelled, difficultly breathing and swallowing (anaphylaxis).  Urgent care rushed me in and gave me dexamethasone in my right arm to stop the swelling as well as Tylenol.  It took about a full week to completely feel normal, mild anxiety  attacks happened.  But after one week felt good again.
Information has been received from an 88 year old male with no pertinent medical history who on 15-DEC-2008 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX (Oka/Merck). On 06-JAN-2009 the patient developed warmth, tingling and a rash on his back. Unspecified medical attention was sought. At the time of the report, 08-JAN-2009, the patient had not recovered from the events. Additional information has been requested.
Left shoulder which was the location of the shot/prick for the shot, has been cracking, creaking, and incredibly sore and achy. Muscles in that area have also been weak and sore since vaccination.
Patient felt dizzy accompanied by blurred vision that lasted 4 Minutes. Gave Patient cold water
The arm it was given in was swollen, red, hot to the touch, and hard. She said all of the arm symptoms spanned about 5 inches up/down her arm and 3 inches across. It also had a white halo/ring around the injection site. Her face was swollen on the same side the flu shot was given in.
COVID-19; COVID-19; This is a spontaneous report from contactable consumer. The reporter is the patient. An 80-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: 004m20a), in left arm, on 26Feb2021 as dose 2, single (Lot number: 023m20a), in left arm, on 21Oct2021 as dose 3 (booster), single (Lot number: 026d21a), in left arm and on 11Mar2022 as dose 4 (booster), single (Lot number: 466k21a) at the age of 79 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Patient had no known allergies. No adverse events from vaccines. The following information was reported: vaccination failure (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: COVID-19 test: positive. Therapeutic measures were taken as a result of vaccination failure, covid-19: anti-viral, from 02Aug2022 to 06Aug2022.
flu; Initial information received on 28-Nov-2022 regarding an unsolicited valid Social-Media non-serious case from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who experienced flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date in Oct-2022(last month), the patient received suspect influenza vaccine produced by unknown manufacturer at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site as flu shot (Influenza immunisation).  On an unknown date in 2022 the patient developed a non-serious flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown for the event flu.
Developed and area of erythema 4.5cm x 6.5cm around the area she received pneumovax. Area was tender and slightly hardened. Patient also experiencing some vomiting. Discharge summary states rash, drug reaction, diarrhea. msv. Per follow up from 01/31/2006 Had problems with R shoulder rotator cuff very soon after going home from hospital. Moderate pain has diminished to slight pain 2 months later. Also had marked increase in arthritis of shoulder, hips, knees, back now relieved by anti inflammatories, but still a problem. It is difficult to say whether the above is related or not, but the timing is certainly coincidental.
About 5 hours later, I startd feeling like I was having flu symptoms; Late afternoon - 99.5 fever and fatigue. By 8:00 p - fever was 100; joint and muscle aches and fatigue; Took Tylenol finally before bed - slept a little bit but woke up with 101 temperature and I took another Tylenol and went back to bed but couldn't sleep because of pain with muscles; sore throat and it went up to 101.4 - it would go down with Tylenol but it would shoot back up after 4 hours. Rollercoaster with that up through Sunday 10th - all day fever was over 101.4 - 101.6 with extreme fatigue; really bad muscle and joint pain; eat a little and pushed fluids. Didn't have to work Monday. Rested and I felt a little tight in my chest and took Albuterol. Monday morning temp was 101; but started going down to 99 range fever; I had a previously schedule visit with my dr. and it ended up being a sick visit. He said to keep an eye on it. He told me not to go to work on Tuesday or Wednesday. Things were getting better but still had sore throat; shortness of breath and muscle aches/joint pain but lower temp. Wednesday night I called out from work because things got worse with my breathing/chest got tight etc  but not fever anymore Had a virtual Urgent care visit - for the COVID test. COVID test on Thursday. Went to back to work - and I still have a slight bit of joint pain.
This spontaneous report was received from a physician via a company representative and refers to a 11 year old female patient (the physician's niece). There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) (exact dose, route of administration, lot # and expiration date were not reported). On an unknown date, after having VARIVAX (Merck) received, the patient experienced shingles. The outcome of shingles was unknown. The relatedness between shingles and VARIVAX (Merck) was not reported. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to a patients of unknown demography. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates the patients were vaccinated with improperly stored dose of GARDASIL 9 lot # N020352 (expiry: 10-APR-2020), N004799 (expiry: 15-NOV-2019) and M044717 (expiry: 19-JUL-2019), improperly stored RECOMBIVAX HB lot # N006321 (expiry: 08-NOV-2019), M045546 (12-JUN-2018) and improperly stored ROTATEQ lot # N005626 (expiry: 26-NOV-2018), M041766 (08-MAY-2018) and M045546 (expiry: 12-JUN-2018). For GARDASIL 9, the temperature and time frame was reported as 47 F to 77 F (57.18F) 14 hours and 50 minutes and there was no temperature excursion. For ROTATEQ, the temperature and time frame was reported as 47 F to 77 F (50.05F) for 225 hours and 57 minutes with previous temperature excursion. For RECOMBIVAX HB, the temperature and time was reported as 47 F to 77 F (57.18F) for 240 hours and 47 minutes with previous temperature excursion. No adverse effects reported. No PQC involved.